SML1630

Bendazac

≥98% (HPLC)

• Sinônimo(s): Bendazolic acid, [(1-Benzyl-1H-indazol-3-yl)oxy]acetic acid
• Fórmula empírica (Notação de Hill): C₁₆H₁₄N₂O₃
• Número CAS: 20187-55-7
• Peso molecular: 282.29
• Número CE: 243-569-2
• Número MDL: MFCD00866158
• Código UNSPSC: 12352200
• ID de substância PubChem: 329825514
• NACRES: NA.77

Propriedades

• Nível de qualidade: 200
• Ensaio: ≥98% (HPLC)
• Formulário: powder
• solubilidade: DMSO: soluble ≥1 mg/mL; methanol: soluble ≥1 mg/mL
• temperatura de armazenamento: 2-8°C
• cadeia de caracteres SMILES: OC(COC1=NN(CC2=CC=CC=C2)C3=CC=CC=C31)=O
• InChI: 1S/C16H14N2O3/c19-15(20)11-21-16-13-8-4-5-9-14(13)18(17-16)10-12-6-2-1-3-7-12/h1-9H,10-11H2,(H,19,20)
• chave InChI: BYFMCKSPFYVMOU-UHFFFAOYSA-N
• Informações sobre genes: human ... XDH(7498)

Descrição

Ações bioquímicas/fisiológicas

Bendazac (or bendazolic acid) is a non-steroidal anti-inflammatory drug used for joint and muscular pain. Bendazac is an anti-denaturant drug for cataract and other condensation diseases. In addition, Bendazac has been used in studies related to potential treatment and pevention of ischemia and reperfusion syndromes, and was found to inhibit only reversible and irreversible xanthine oxidase.

Bendazac is a non-steroidal anti-inflammatory drug used for joint and muscular pain.

Informações de segurança

• Código de classe de armazenamento: 11 - Combustible Solids
• Classe de risco de água (WGK): WGK 3